Posted inBiotechnology
New Metrics Unveil Wildfire Smoke Exposure Patterns
In recent years, the increasing frequency and intensity of wildfires have raised significant public health concerns worldwide. Among the most…
Posted inBiotechnology
Groundbreaking Photonics Technique Enables Light to Circulate on a Chip for Millions of Cycles
In a groundbreaking development poised to redefine the landscape of integrated photonics, researchers at Aalto University, in collaboration with international…
Posted inBiotechnology
Scientists Harness Ultrasound to Generate Light Within the Body
In a remarkable breakthrough that could fundamentally transform how light is delivered within biological tissues, researchers at Stanford University have…
Posted inBiotechnology
Spyre points to phase 2 win for ulcerative colitis drug as proof it could take on Takeda’s Entyvio
Spyre Therapeutics’ monoclonal antibody hit the key goal in a phase 2 study for ulcerative colitis (UC), which the company…
Posted inBiotechnology
AbbVie inks $745M deal with Chinese biotech Haisco for two acute pain assets
AbbVie has agreed to pay $30 million upfront to Haisco Pharmaceutical Group for ex-China rights to two non-opioid pain treatment…
Posted inBiotechnology
Correcting Genetic Links: TMEM175, SCARB2, CTSB in Parkinson’s
In an era marked by relentless advancements in neurogenetics, recent developments have shed new light on the intricate genetic architecture…
Posted inMedical Technology
Retractable Technologies trims staff to save $2.2M annually as tariffs bite
Retractable Technologies, the maker of a retractable needle and other safety medical products, is cutting roughly 16% of its workforce…
Posted inBiotechnology
Generalized Doppler Effect Enhances Frequency Shift Accuracy
In a breakthrough that promises to revolutionize high-precision frequency measurements, researchers Zhang, Ba, Yang, and colleagues have unveiled a novel…
Posted inBiotechnology
Hearing Loss Trends in Older Adults: Sex Differences
In a striking new study published in BMC Geriatrics, researchers have brought to light important revelations about the prevalence and…
Posted inBiotechnology
Ideaya sees clear path to FDA as Servier-partnered eye cancer drug hits goal in phase 2/3 trial
A phase 2/3 trial of Ideaya Biosciences and Servier’s eye cancer candidate has hit its primary endpoint, teeing up a filing…